Results

Total Results: 784 records

Showing results for "buprenorphine".

61. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
    June 09, 2020 - Trials of methadone or buprenorphine detoxification (withdrawal management) were excluded. … Results of trials of methadone and buprenorphine are summarized in Table 3 . … There was no significant difference between type of drug (methadone or buprenorphine), buprenorphine … Pharmacological Therapies Opioid Agonist Therapy (Buprenorphine or Methadone). … buprenorphine/naloxone.

62. Opioid Treatments for Chronic Pain | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/research
    April 16, 2020 - Trials of patients with prescription opioid dependence found buprenorphine maintenance associated with … better outcomes than buprenorphine taper and similar effects of methadone versus buprenorphine.

63. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=52
    January 01, 2024 - , difficulty hiring buprenorphine providers, managing tension between harm reduction and traditional … Implementation facilitators included receiving technical assistance from DOHMH, having designated buprenorphine … coordinator and ensure regular training on buprenorphine for frontline staff, and (3) buprenorphine … providers should be selected or supported to use a harm reduction approach to buprenorphine treatment … Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation

64. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
    June 09, 2020 - Trials of methadone or buprenorphine detoxifica- tion (withdrawal management) were excluded. … There was no significant difference between type of drug (methadone or buprenorphine), buprenorphine … Pharmacological Therapies Opioid Agonist Therapy (Buprenorphine or Methadone) | Four trials of buprenorphine … Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. … buprenorphine/naloxone.

65. County-Level Determinants of High Opioid-Related Hospitalization Rates (pdf file)
    hcup-us.ahrq.gov/reports/CountyHighOpioidHospitalRates.pdf
    December 01, 2020 - As part of medication- assisted therapy, buprenorphine is an evidence-based treatment for opioid use … For example, our measure of buprenorphine-waivered physicians may not accurately capture access to buprenorphine … Buprenorphine. … Updated May 31, 2016. https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine. … Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment

66. AHRQ Topic Brief Supports Primary Care Treatment of Opioid Use Disorder | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/oud-brief.html
    October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine

67. Appendixes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendixes-surveillance-report-1.pdf
    September 30, 2021 - (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain.

68. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - • One small new RCT of buprenorphine/naloxone versus methadone for treatment of opioid use disorder … Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain.

69. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=21
    June 27, 2021 - of Food and Drug Administration (FDA)-approved pharmacotherapies for opioid use disorder (methadone, buprenorphine … interval [CI] 0.62 to 0.85; number needed to treat [NNT] 5.3) and opioid agonist therapy with methadone or buprenorphine … Naltrexone and methadone/buprenorphine therapy were also associated with increased likelihood of retention

70. A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales. | PSNet
    psnet.ahrq.gov/issue/mixed-methods-analysis-patient-safety-incidents-involving-opioid-substitution-treatment
    October 12, 2016 - mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine … mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine … Methadone and buprenorphine are commonly prescribed to treat opioid use disorder , but their use presents … reports and found that harmful incidents involving opioid substitution treatment with methadone or buprenorphine … mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine

71. CountyNeonatalAbstinenceSyndrome (pdf file)
    hcup-us.ahrq.gov/reports/CountyNeonatalAbstinenceSyndrome.pdf
    November 19, 2021 - Buprenorphine-waivered physicians were more than twice as common in counties with high NAS rates than … Higher rates of buprenorphine-waivered physicians were associated with higher NAS rates. … This may suggest that areas with greater access to buprenorphine-waivered physicians have more pregnant … Comparison between buprenorphine provider availability and opioid deaths among US counties. … Neonatal abstinence syndrome after methadone or buprenorphine exposure.

72. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone

73. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients … Buprenorphine Buccal Film Improves Patient Global Impression of Change and Reduces the Prevalence … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone

74. Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent Hospitalizations | PSNet
    psnet.ahrq.gov/web-mm/lost-transitions-care-managing-opioid-dependent-patient-frequent-hospitalizations
    October 27, 2022 - After this consultation, the patient was started on transdermal extended-release buprenorphine 5 mcg/ … Buprenorphine is also a complex medication to use for managing chronic pain. … offers recommendations for starting buprenorphine doses based on current OME. … Butrans(buprenorphine) [package insert]. … Butrans (buprenorphine) Transdermal System. https://butrans.com/dosing/dosage.html .

75. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Buprenorphine implant (Probuphine) for treatment of opioid dependence No high-impact potential at this … The topic, buprenorphine implant (Probuphine™, Titan Pharmaceuticals, Inc., South San Francisco, CA … followed by a buprenorphine implant placed under the skin in a physician’s office and removed after … Available short-acting treatments for opioid dependence (e.g., naltrexone, methadone, buprenorphine … The 6-month buprenorphine implant completed phase III trials, one of which was funded by the National

76. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=107
    January 01, 2024 - The treatment analyzed was use of buprenorphine. … Only 1 in 10 eligible individuals with OUD initiated buprenorphine within 365 days of diagnosis with … 2850 individuals (6.3%) initiating buprenorphine within 14 days of diagnosis. … Of the 4600 individuals who received buprenorphine, half were maintained in care with 180 days or more … Quality of buprenorphine care for insured adults with opioid use disorder.

77. Recent Data Analyses | Agency for Healthcare Research and Quality
    www.ahrq.gov/opioids/data/analyses.html
    November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268 Price elasticity of demand for buprenorphine

78. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic … Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Optimizing opioid use disorder treatment with naltrexone or buprenorphine.

79. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - Treatment of opioid use disorder (buprenorphine/naloxone vs. methadone) No difference between buprenorphine … Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic … Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder … Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. … Optimizing opioid use disorder treatment with naltrexone or buprenorphine.

80. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=54
    January 01, 2024 - Systems, Medicaid, Healthcare Delivery Jakubowski A , Norton BL , Hayes BT Low-threshold buprenorphine … They found that, in an SSP-based low-threshold buprenorphine treatment program, approximately one-third … of patients continued buprenorphine treatment for 180 days or more, and buprenorphine adherence was … They concluded that SSPs can be a pathway to buprenorphine treatment for patients at high risk for opioid-related … Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes